Prestige Consumer Healthcare Inc.

Ladies and gentlemen, thank you for standing by and welcome to the Q3 2021 Prestige Consumer Healthcare Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there'll be a question and answer session. To ask a question during the session, you'll need to press star one on your telephone. Please be advised that today's conference is being recorded. If you require any further assistance, please press star zero. I would now like to hand the conference over to your speaker today, Phil Terpolilli, Head of Investor Relations. Please go ahead, sir.

Thanks, Operator, and thank you to everyone who has joined today. On the call with me are Ron Lombardi, our Chairman, President, and CEO, and Chris Sacco, our CFO. On today's call, we'll cut for the results of our third quarter and fiscal year to date provide an outlook update, and then take questions from analysts. We have a slide presentation that accompanies today's call. It can be accessed by visiting PrestigeConsumerHealthcare.com, clicking on the Investors link, and then on today's webcast and presentation. Please remember some of the information contained in the presentation today includes non-GAAP financial measures. Reconciliations to the nearest GAAP financial measures are included in today's earnings release and slide presentation. During today's call, management will make forward-looking statements around risks and uncertainties, which are detailed in a complete safe harbor disclosure on page two of the slide presentation accompanying the call. These are important to review and contemplate. As everyone on the call today is aware, business environment uncertainty remains heightened due to COVID-19. These items include shutdown impacts for many areas of the economy, changes to consumer purchasing habits, potential for a disrupted supply chain, and various other economic factors. This means that results could change at any time and the forecasted impact of risk considerations is the best estimate based on information available as of today's date. Additional information concerning risk factors and cautionary statements are available in our most recent SEC filings and the most recent Company 10-K. I'll now hand it over to our CEO, Ron Lombardi. Ron?

Thanks, Phil. Good morning, everyone, and let's start on slide five. Our proven business model continues to set us up for long-term success, and the strong earnings performance and stable top-line year-to-date results is continued evidence of this as we have raised our full-year revenue and earnings targets. The business strategy we have in place is a highly adaptable one, which positions us to create value during the pandemic. Our strategy of offering consumers a wide range of easily accessible brands they know and trust continues to work. The ongoing objective is to grow categories while connecting with consumers over the long term. We'll share one example of this long-term strategy, Compound W, on the next slide. Despite the long-term nature of these investments, we are also quick to target near-term opportunities. This important nuance allows us to adjust our brand building strategy in real time, finding additional ways to deliver brand growth. For example, as discussed the last two quarters, we've focused on prioritization on where consumers are shopping. A result of this is that we are winning big in e-commerce, where we've seen triple-digit growth, and many of our brands actually have a higher share in the channel compared to brick and mortar. Meanwhile, our nimble business continuity efforts continue to do well during COVID-19. We continue to work strategically with our manufacturing partners to ensure consistent service levels in this dynamic supply environment. Finally, our consistent operating model and disciplined capital strategy continue to reward shareholders. We anticipate solid earnings and free cash flow growth for the full fiscal year, which continues to increase our capital allocation optionality. So to recap, our business positioning remains solid and our strategy is delivering consistent results as we close out our fiscal year. Now let's turn to slide six to discuss Compound W. Even during this unique time, we have not lost sight of the importance of long-term brand building. Utilizing our brand building toolkit and taking time to understand consumer insights, the goal is to drive long-term growth for our leading brands. Shown on the page, we have Compound W, which is a great example of this objective. It's a brand with a long history with consumers, and we've invested steadily behind it through a wide range of tools over time. One tool used is innovation. All of our brands operate with a multi-year pipeline of product development concepts to ensure we continue to match the needs of consumers. Compound W Nitro Freeze is a great recent example with its extreme freezing technology that is not found in other OTC treatments. We are also connecting with consumers as they think about treatment with content that helps explain their work treatment options. For example, during the pandemic, we've reminded consumers of the ability to treat warts effectively at home and the solutions Compound W offers. The result of our investment behind Compound W is clear. We have a trusted source for retailers for insights into the wart category and how to drive long-term category growth. This has enabled our brand to continue to gain shelf space and share. Our results have been solid. Over the last five years, Compound W has grown at a double-digit compound annual rate, vastly outpacing category growth and solidifying its number one market position with consumers as a preferred brand for work treatment. With that, I'll now hand it over to Chris to review our financial results.